Fig. 1From: Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settingsLayout for evaluation of Pfs25-IMX313in Matrix-M; Pfs25-immunized serum samples from vaccinated volunteers will be collected and mixed with field or cultured gametocyte isolates and fed to laboratory-reared mosquitoes to determine the ex-vivo efficacy of the vaccine candidate in form of transmission blocking [102] and reducing [50] activitiesBack to article page